← All trials
NCT01197846
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2010
- Primary completion
- Feb 1, 2012
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Centro de Investigación Biomédica en Red (CIBER)Lead sponsor
- University of BarcelonaOverall official - principal investigator
- Hospital Santiago Apostol. Vitoria. SpainOverall official - principal investigator
- Centro de Salud Mental II. Oviedo. SpainOverall official - principal investigator
- University of ValenciaOverall official - principal investigator
- Universidad Complutense de MadridOverall official - principal investigator
- Centro de Investigación Biomédica en Red (CIBER)Reponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.